Cycloadenosine Glucoside for Injection

Cyclic adenosine meglumine is a non-digitalis cardiotonic agent with positive inotropic effect. It can enhance myocardial contractility, improve myocardial pump function, dilate blood vessels, and reduce myocardial oxygen consumption. It can improve myocardial cell metabolism and protect ischemic and hypoxic myocardium. It can improve the function of sinoatrial node P cells.

Cyclic adenosine meglumine, excipient: mannitol.

This medicine is used for heart failure, myocarditis, sick sinus syndrome, coronary heart disease and cardiomyopathy, and can be used as an auxiliary treatment for arrhythmias.

1. Intravenous drip: add 200-500ml 5% glucose injection solution to dissolve and then intravenously drip, once a day, 60-180mg each time; 2. Intravenous push: add 20-40ml 25% or 10% glucose injection to dissolve and then slowly push intravenously, once a day, 90mg each time.

Occasionally, symptoms such as palpitations, heart palpitations, and dizziness may occur.

1. Those who are allergic to any ingredient in the drug. 2. This product is contraindicated for simultaneous intravenous administration with aminophylline.

Precautions for children: This experiment has not been conducted and there is no reliable reference. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: This experiment has not been conducted and there is no reliable reference.

This product is contraindicated for simultaneous intravenous administration with aminophylline.

Keep tightly closed in a cool place.

60mg

12 months.

Shanghai Fudan Fuhua Pharmaceutical Co., Ltd.

• Founded in:

  1981-12-01

• Address:

  No. 1399 Shuguang Road, Minhang District, Shanghai

• Tax NO.:

  91310112132661556L

• Registered Funds:

  44.8 million yuan

• Email:

  Log in to view